期刊文献+

不同方案治疗带状疱疹神经痛疗效比较 被引量:5

Efficacy Comparison between Different Treatments for Herpes Zoster Neuralgia
原文传递
导出
摘要 目的比较不同治疗措施治疗带状疱疹神经痛的止痛效果,优化带状疱疹神经痛治疗方案。方法通过军卫一号病案管理系统,收集2009年1月1日-2013年12月20日带状疱疹住院患者资料,按治疗措施不同分为5组。A组:盐酸伐昔洛韦胶囊+盐酸多塞平片;B组:盐酸伐昔洛韦胶囊;C组:盐酸伐昔洛韦胶囊+盐酸奈福泮片+盐酸多塞平片;D组:盐酸伐昔洛韦胶囊+盐酸奈福泮片;E组:盐酸伐昔洛韦胶囊+非甾体类抗炎药(包括尼美舒利胶囊、布洛芬胶囊)。统计每组患者性别、年龄、发病至入院时间、治疗后疼痛消失时间,统计分析不同治疗方案患者疼痛消失时间的差异。结果共收集病案资料898份,符合上述5组要求者336例,A、B、C、D、E组分别为72、86、66、60、52例,治疗后疼痛消失时间分别为(5.94±2.54)、(8.60±3.09)、(5.77±1.85)、(5.80±1.96)、(6.86±2.18)d;治疗后疼痛消失时间B组与其余4组差异均有统计学意义(P<0.05);E组与A、C、D组间差异有统计学意义(P<0.05),A组、C组与D组间差异无统计学意义(P>0.05)。结论以上治疗方案均对带状疱疹神经痛治疗有效。盐酸奈福泮片和盐酸多塞平片治疗效果优于尼美舒利胶囊和布洛芬胶囊。盐酸奈福泮片和盐酸多塞平片疗效无差别,且两者联用不增加疗效。 Objective To compare the analgesic effect of different treatment for herpes zoster neuralgia,and optimize herpetic neuralgia treatment.Methods We collected hospital inpatient data with herpes zoster by the First Military Medical Case Management System between January 1 st,2009 and December 20 th,2013.All the patients were divided into five groups according to different treatments.Patients in group A accepted valaciclovir capsules and doxepin hydrochloride tablets; patients in group B accepted valaciclovir capsules; patients in group C accepted valaciclovir capsule,nefopam hydrochloride tablets and doxepin hydrochloride tablets; patients in group D accepted valaciclovir capsules and nefopam hydrochloride tablets; patients in group E accepted valaciclovir capsules and non-steroidal anti-inflammatory drugs(including nimesulide capsules and ibuprofen sustained-release capsules).We collected such statistic data as sex,age,time of onset,time of pain disappearing after treatment.Then,we analyzed the difference among the groups on the time of pain disappearing.Results There were 336 cases compliant with the standard in all the 898 cases of medical record data.The number of the patients was 72,86,66,60 and 52; while the pain disappearing time after treatment was( 5.94 ± 2.54),( 8.60 ± 3.09),( 5.77 ± 1.85),( 5.80 ± 1.96) and( 6.86 ± 2.18) days,respectively in group A,B,C,D and E.Pain disappearing time after treatment of group B was significantly different from groups A,C,D,and E( P 〈0.05); group E was significantly different from groups A,C,and D( P 〈0.05); there was no significant difference between group A and groups C and D,and between group C and D( P〉0.05).Conclusions The combination of nefopam hydrochloride tablets,doxepin hydrochloride tablets,nimesulide capsules,and ibuprofen sustained-release capsules is effective in the treatment of herpes zoster neuralgia.The use of nefopam hydrochloride tablets with doxepin hydrochloride tablets is more effective than the combinati
出处 《华西医学》 CAS 2015年第7期1243-1245,共3页 West China Medical Journal
关键词 带状疱疹 神经痛 奈福泮 多塞平 Herpes zoster Neuralgia Nefopam Doxepin
  • 相关文献

参考文献7

  • 1赵辨主编..中国临床皮肤病学[M].南京:江苏科学技术出版社,2010.
  • 2洪淑超,曹任凤.非甾体抗炎药不良反应危险因素初探[J].安徽医药,2012,16(1):130-132. 被引量:15
  • 3陈新谦, 金有豫, 汤光. 新编药物学[M]. 北京: 人民卫生出版社, 1992: 176. 被引量:1
  • 4Tigerstedt I, Sipponen J, Tammisto T, et al. Comparison of nefopam and pethidine in postoperative pain[J]. Br J Anaesth, 1977, 49(11): 1133-1138. 被引量:1
  • 5Chanques G, Sebbane M, Constantin JM, et al. Analgesic efficacy and haemodynamic effects of nefopam in critically ill patients[J]. Br J Anaesth, 2011, 106(3): 336-343. 被引量:1
  • 6Sammeta SM, Vaka SR, Murthy SN. Transcutaneous electroporation mediated delivery of doxepin-HPCD complex: a sustained release approach for treatment of postherpetic neuralgia[J]. J Control Release, 2010, 142(3): 361-367. 被引量:1
  • 7袁金秋,杨克虎,刘雅莉,杨声坪.多虑平治疗原发性失眠有效性及安全性的系统评价[J].中国循证医学杂志,2010,10(11):1325-1330. 被引量:13

二级参考文献20

  • 1施桂英.昔布类药物相关的心血管事件[J].药物不良反应杂志,2005,7(1):5-7. 被引量:7
  • 2宿长军,刘煜,李柱一,林宏,李宏增,苗建亭.黛力新与多塞平联合治疗原发性失眠[J].第四军医大学学报,2005,26(21):2010-2012. 被引量:17
  • 3王桂清,赵克虎.扩血管药联合多虑平治疗中老年人慢性失眠52例[J].实用医药杂志,2006,23(7):863-863. 被引量:3
  • 4Ohayon MM. Epidemiology of insomnia: what we know and what we still need to learn. Sleep Medicine Reviews, 2002, 6(2): 97-111. 被引量:1
  • 5Daley M, Morin CM, LeBlanc M. The economic burden of insomnia: direct and indirect costs for individuals with insomnia syndrome, insomnia symptoms, and good sleepers. Sleep, 2009, 32 (1): 55-64. 被引量:1
  • 6Hajak G, Rodenbeck A, Voderholzer U. Doxepin in the treatment of primary insomnia: a placebo-controlled, double-blind, polysomnographic study. J Clin Psychiatry, 2001, 62(6): 453-463. 被引量:1
  • 7Rodenbeck A, Cohrs S, Jordan W. The sleep-improving effects of doxepin are paralleled by a normalized plasma cortisol secretion in primary insomnia. Psychopharmacology (Berl), 2003, 170(4): 423-428. 被引量:1
  • 8Roth T, Rogowski R, Hull S. Efficacy and safety of doxepin 1 mg, 3 rag, and 6 mg in adults with primary insomnia. Sleep, 2007, 30(11): 1555-1561. 被引量:1
  • 9Scharf M, Rogowski R, Hull S, et al. Efficacy and safety of doxepin 1 mg, 3 rag, and 6 mg in elderly patients with primary insomnia: a randomized, double-blind, placebo-controlled crossover study. J Clin Psychiatry, 2008, 69(10): 1557-1564. 被引量:1
  • 10Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 (updated September 2008). The Cochrane Collaboration, 2008. Available from www. cochranehandbook.org. 被引量:1

共引文献26

同被引文献34

引证文献5

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部